Aspen Of S. Africa To Buy GSK Line Of OTC Drugs For $263 Million
This article was originally published in PharmAsia News
Executive Summary
South Africa’s Aspen Pharmacare plans to buy GlaxoSmithKline PLC’s line of over-the-counter drugs, primarily painkiller drugs, for $263 million.